Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis

Autor: Hengameh Chloé Mirsepasi-Lauridsen, Tine Thorkilgaard, Andreas Petersen, Marianne K Vester-Andersen, Ida Vind, K. Skovsen, Michelle V. Prosberg, Nikolaj Sørensen, C. O. Mortensen, C. Nojgaard, C. Träger, Flemming Bendtsen, Karen A. Krogfelt

Publikováno v: Scientific Reports
Vester-Andersen, M K, Mirsepasi-Lauridsen, H C, Prosberg, M V, Mortensen, C O, Träger, C, Skovsen, K, Thorkilgaard, T, Nøjgaard, C, Vind, I, Krogfelt, K A, Sørensen, N, Bendtsen, F & Petersen, A M 2019, ' Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis ', Scientific Reports, vol. 9, no. 1, 13473 . https://doi.org/10.1038/s41598-019-49833-3
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)

Intestinal dysbiosis in inflammatory bowel disease (IBD) patients depend on disease activity. We aimed to characterize the microbiota after 7 years of follow-up in an unselected cohort of IBD patients according to disease activity and disease severit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9656ff10e83cb153615d0700d709bb0
http://europepmc.org/articles/PMC6748953

Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease

Autor: Dorte Marker, Katrine Carlsen, Pia Munkholm, Henriette Elsberg, Johan Burisch, Tine Thorkilgaard, Margarita Elkjaer, Erika Belard, Kristoffer K. Vinding, Natalia Pedersen

Publikováno v: Inflammatory bowel diseases. 22(2)

Background Fecal calprotectin is a reliable noninvasive marker for intestinal inflammation usable for monitoring patients with inflammatory bowel disease. Tests are usually performed by enzyme-linked immunosorbent assay (ELISA), which is time consumi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646209372fcbdda4ade225a8c9dd0987
https://pubmed.ncbi.nlm.nih.gov/26535869

1024 Faecal Calprotectin Measured by IBD Patients at Home - A New Clinical Tool

Autor: Johan Burisch, Tine Thorkilgaard, Dorte Marker, Henriette Elsberg, Pia Munkholm, Katrine Carlsen, Natalia Pedersen, Kristoffer K. Vinding

Publikováno v: Gastroenterology. 148:S-193

significantly younger, had shorter disease duration and underwent a greater number of CD related surgeries during the study period (Table 1). For the entire study cohort, LS1 ranged from 0-54 (mean 8.76±6), LS2 ranged from 0-46 (mean 9.98±8) and DL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2f3e96b7b177214f2a5b96d94bfb9a6
https://doi.org/10.1016/s0016-5085(15)30641-7